---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-047591"
form_type: "8-K"
ticker: "AZTA"
cik: "0000933974"
company_name: "Azenta, Inc."
filed_at: "2026-07-08T12:03:36+00:00"
generated_at: "2026-07-08T12:05:05.886854+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Azenta completes sale of B Medical Systems for $63M; $35M vendor loan to buyer

## Summary
- Sale closed July 1, 2026; fixed purchase price $63M: $28M cash at closing, $35M via secured vendor loan.
- Vendor loan from Azenta Germany GmbH to Thelema at 6% interest, matures 3 months from funding date.
- Thelema majority-owned by Luc Provost (Azenta VP & B Medical CEO); Audit Committee approved related-party terms.
- Pro forma balance sheet as of Mar 31, 2026 shows net cash proceeds $19M and $35M note receivable from Thelema.
- Azenta CEO states sale simplifies portfolio and positions company for sustainable growth in core life sciences.

## SEC filing metadata
- accession: 0001628280-26-047591
- form_type: 8-K
- ticker: AZTA
- cik: 0000933974
- company_name: Azenta, Inc.
- filed_at: 2026-07-08T12:03:36+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/933974/000162828026047591/0001628280-26-047591-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/933974/000162828026047591/azta-20260701.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-047591
- JSON: https://secwatch.observer/filing/0001628280-26-047591.json
- Plain text: https://secwatch.observer/filing/0001628280-26-047591.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.